{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:45:50Z","timestamp":1782913550443,"version":"3.54.5"},"reference-count":14,"publisher":"The Journal of Rheumatology","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2026,2,5]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The previously developed FLARE questionnaire assesses the multidimensional aspects of a flare of psoriatic arthritis (PsA). We aimed to further validate this questionnaire.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Reanalysis of data from the ReFLAP study (ClinicalTrials.gov:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03119805\">NCT03119805<\/jats:ext-link>\n                      ), a longitudinal observational study carried out in 14 countries. Demographic, clinical, and patient-reported data were collected at baseline and 1 follow-up visit. The FLARE questionnaire (range 0-10) was completed at both timepoints (mean interval 4.5 months). Using a patient anchor question for perceived flare (yes\/no), the optimal cutoff for defining a flare was obtained using receiver-operating characteristic curve analysis. Based on this cutoff, patients were compared for flare (yes\/no) using clinical and patient-reported data, including composite measures of disease activity. The magnitude of score differences in patients experiencing a new flare at second visit were compared with independent samples\n                      <jats:italic>t<\/jats:italic>\n                      -scores.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 147 patients, 61 (41%) reported a flare at baseline; the optimal score cutoff from the FLARE questionnaire was 4 (sensitivity 0.86, specificity 0.76) and, using this cutoff, patients in flare had significantly worse clinical and patient-reported outcomes. Of those patients reporting a flare, the most frequently affirmed items from the questionnaire referred to pain, mobility, frustration, and fatigue. Those with a new flare at the second visit had patient-reported and clinical change scores significantly worse than those not reporting a flare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study has provided further data on the FLARE questionnaire performance and validity. The questionnaire is ready for use in clinical trials and longitudinal observational studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.2025-1296","type":"journal-article","created":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T12:20:22Z","timestamp":1773577222000},"page":"752-756","source":"Crossref","is-referenced-by-count":0,"title":["Further Validation of a Questionnaire to Assess Flare in Psoriatic Arthritis: Determination of Cutoff and Longitudinal Change"],"prefix":"10.3899","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4155-9105","authenticated-orcid":false,"given":"Philip S.","family":"Helliwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2606-0573","authenticated-orcid":false,"given":"Juan D","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4756-663X","authenticated-orcid":false,"given":"Laura C.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-5328","authenticated-orcid":false,"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9307-089X","authenticated-orcid":false,"given":"Sandra","family":"Meisalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-8567","authenticated-orcid":false,"given":"Ana Maria","family":"Orbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0132-4325","authenticated-orcid":false,"given":"Penelope","family":"Palominos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-2138","authenticated-orcid":false,"given":"Adeline","family":"Ruyssen-Witrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2889-8962","authenticated-orcid":false,"given":"Rossana","family":"Scrivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4302-8877","authenticated-orcid":false,"given":"Josef S.","family":"Smolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8428-6354","authenticated-orcid":false,"given":"Maarten","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-310X","authenticated-orcid":false,"given":"Laure","family":"Gossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2026,3,15]]},"reference":[{"key":"2026070105202358000_53.7.752.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1505557"},{"key":"2026070105202358000_53.7.752.2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev009"},{"key":"2026070105202358000_53.7.752.3","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160118"},{"key":"2026070105202358000_53.7.752.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.08.011"},{"key":"2026070105202358000_53.7.752.5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214140"},{"key":"2026070105202358000_53.7.752.6","doi-asserted-by":"crossref","first-page":"105511","DOI":"10.1016\/j.jbspin.2022.105511","article-title":"Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countries","volume":"90","author":"Sousa","year":"2023","journal-title":"Jt Bone Spine"},{"key":"2026070105202358000_53.7.752.7","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1093\/rheumatology\/keaf002","article-title":"Variability of psoriatic arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study","volume":"64","author":"L\u00f3pez-Medina","year":"2025","journal-title":"Rheumatology"},{"key":"2026070105202358000_53.7.752.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.23568"},{"key":"2026070105202358000_53.7.752.9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.122259"},{"key":"2026070105202358000_53.7.752.10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.102053"},{"key":"2026070105202358000_53.7.752.11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.201675"},{"key":"2026070105202358000_53.7.752.12","first-page":"193","article-title":"Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis","volume":"37","author":"Scriffignano","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2026070105202358000_53.7.752.13","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1093\/rheumatology\/keaf247","article-title":"Psoriatic arthritis flare incidence, definition and risk factors: a systematic review","volume":"64","author":"Hojeij","year":"2025","journal-title":"Rheumatology"},{"key":"2026070105202358000_53.7.752.14","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/art.42780","article-title":"Difficult-to-treat psoriatic arthritis: a conceptual approach","volume":"76","author":"Fagni","year":"2024","journal-title":"Arthritis Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2025-1296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:57:31Z","timestamp":1782910651000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2025-1296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":14,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,1]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.3899\/jrheum.2025-1296"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2025-1296","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,15]]}}}